{"@id":"https://bioecon.ru/technology/synthetic-virus-like-particle-immunotherapy/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://cn.bioecon.ru/technology/synthetic-virus-like-particle-immunotherapy/","json":"https://cn.bioecon.ru/api/v1/technology/synthetic-virus-like-particle-immunotherapy/index.json"},"id":"synthetic-virus-like-particle-immunotherapy","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lignovations-gmbh/","https://bioecon.ru/companies/isomerase/","https://bioecon.ru/companies/phageguard/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/genscript-probio-genscript/","https://bioecon.ru/companies/giant-biogene-holding/","https://bioecon.ru/companies/lignopure-gmbh/","https://bioecon.ru/companies/spiber-technologies-ab/","https://bioecon.ru/companies/fermelanta/"]},"maturity":7,"name":"高密度几何表位展示合成病毒样颗粒（VLP）免疫治疗","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"衣壳蛋白工程发酵与体外自组装"},{"n":2,"title":"超高密度准晶体空间多肽化学偶联"},{"n":3,"title":"空心颗粒内部TLR9核酸佐剂精准封装"},{"n":4,"title":"打破B细胞无反应性逆转慢性非传染性疾病"}],"summary":"基于重组自组装病毒衣壳蛋白纳米结构（如Qβ噬菌体、乙肝核心抗原HBcAg），以5-10纳米严格几何间距高密度展示靶向短肽，通过强力交联B细胞受体彻底打破对自体致病靶标（IL-1β、PCSK9、IgE）的免疫耐受。","url":"/technology/synthetic-virus-like-particle-immunotherapy/","verified":"2026-11-22"}